EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS019-02150 
Organism
Homo sapiens 
Tissue/cell
CD20+ 
Coordinate
chr10:73729570-73731370 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
MAFFMA0495.3chr10:73730947-73730962GAGCTGAGTCAGCGA-6.05
MAFFMA0495.3chr10:73730947-73730962GAGCTGAGTCAGCGA+6.1
RREB1MA0073.1chr10:73730010-73730030CCCCCCACCACCTCCTCACA+6.43
ZNF263MA0528.1chr10:73730004-73730025CCCTCACCCCCCACCACCTCC-6.08
ZNF263MA0528.1chr10:73730001-73730022TCCCCCTCACCCCCCACCACC-6.22
ZNF263MA0528.1chr10:73731314-73731335TTCCCCCTCCTCTCCTCCCTT-6.29
ZNF263MA0528.1chr10:73731306-73731327TTTCCCGCTTCCCCCTCCTCT-6.71
ZNF263MA0528.1chr10:73731318-73731339CCCTCCTCTCCTCCCTTCCTC-6.83
Number of super-enhancer constituents: 24             
IDCoordinateTissue/cell
SE_00376chr10:73730462-73732061Adipose_Nuclei
SE_00890chr10:73728264-73731541Adrenal_Gland
SE_01702chr10:73729991-73737296Aorta
SE_03170chr10:73728186-73729916Brain_Angular_Gyrus
SE_03170chr10:73730522-73732213Brain_Angular_Gyrus
SE_03943chr10:73728232-73743563Brain_Anterior_Caudate
SE_04798chr10:73727845-73748768Brain_Cingulate_Gyrus
SE_05790chr10:73728054-73748631Brain_Hippocampus_Middle
SE_06730chr10:73728098-73748557Brain_Hippocampus_Middle_150
SE_07761chr10:73727829-73748603Brain_Inferior_Temporal_Lobe
SE_08800chr10:73729847-73730059Brain_Mid_Frontal_Lobe
SE_08800chr10:73730674-73731014Brain_Mid_Frontal_Lobe
SE_26917chr10:73729307-73731848Esophagus
SE_29757chr10:73730465-73732147Fetal_Muscle
SE_31814chr10:73728246-73733811Gastric
SE_36082chr10:73729490-73732112HMEC
SE_36975chr10:73727846-73743322HSMMtube
SE_42457chr10:73728200-73733866Lung
SE_46483chr10:73728109-73731704Osteoblasts
SE_46661chr10:73730789-73731330Ovary
SE_47649chr10:73729670-73730093Pancreas
SE_48621chr10:73729126-73737386Right_Atrium
SE_51872chr10:73730145-73732694Skeletal_Muscle_Myoblast
SE_63666chr10:73729615-73737242HSMM
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr107372978973730000
chr107372961273729735
Enhancer Sequence
AGGGGCCGTG AATGCTTCTG CTGGGAACTC CTAGAGTGGC GGCACAGAGA GGGTCTTTGC 60
TGCGAAGGAA CACTCAGAGA GTCTCTGGCT TTCGTGAGGT TATGCCTCAG GAGAGGAGAC 120
ACTTCTCCTT TTCATTCGTT AAACAGAAAT GATATTTGCC ACCTTTTCTT CTCTAAGGCC 180
TAAAGAGATG ACAGAATGCT GCTGGTCCTA CCCTGAGCGC GTGGACTCCA CAGCGGGGTG 240
TGGGGTGGCC CCTGGCAGGC CTGGACGGTT TGTTCTGTGC TTGCCGGTGG ACACGCTTCA 300
GCCCTCTGTC TCTATTGCCC CAAATCTGGC CTGTGGCTGC TGGGCCGCCA CCAGCTTGGA 360
GGGCAGGGTG GGCCCCGGGA GCCCCTGACC ACCAGTGACT TCTTGTCTCC AGCTGCCCTC 420
CGTCCTCTTG ATCCCCCTCA CCCCCCACCA CCTCCTCACA AAGATGGCTG TGTGCTGAGG 480
GACTGTGGCT TCCCTGGGCC CTAGGAAATT TATCACTGAG GTTTCAGAGG ACTCTATGAA 540
AAGGATTTGG AGAAAAAGTG TGGAAAATAA ACAAGCCAGT TCCCAGTTCA GCCTCTCCTG 600
AATGCCGCAA GTAAACAACC ACCTCGGAGG CCAGCCCGGG ATGTTCTTAT TTGGCCTCTG 660
TGGTTACACC TGCCCCCTCC CCGCCCAGTC CCTCCTCCTT AACTTTAAGA GCCTCAAAAG 720
TCAGGGAACA CACCCTCCGC TGGCCAGTCC TTGTGCTGCA GGGACGCTGG TGGCTGGGCA 780
CAGGAGGAAC ATGTATATGG GAGAGAAGAC GGCCGGGGGT CCCAGCTCAG CCCTGCTCCC 840
TCTGAGTCAG TCCCAAGCCT GGACCCTCCC CAGCAGGCAG ACGGTGACGT CTTGGTTGGT 900
TGGTGAGTTT AACTTTGATG GTGCAGAATG ATGAGACTTT TCTCCATTTT GTGGCATCTG 960
AGAAGCTTTG CTTCTTAAAC ATTGCTTTAG GGTGGATAGA CCAAAGCTAA TTTTCCCGTT 1020
ATGTCTCTCC AAGACGGGGC CTACCTGTGA GCAAACCCTC ATAGATTCAT TTACTTTGTA 1080
GGCTACCTGG ACAAAAATGT CAGGTTTCTT TGCTTTGGGC TGGAGTCCTA TCAGCTCAGG 1140
GGTGGTGGTG TAAGGTCACA CCAATGATTT CCAGAAACTC AAGCACTATT CTGAGTGACT 1200
AAGTCTGTGG GATAGGAAGC ACATTTTCCA TCTCTTAATA ACTTCAATTT ACTTAGTGAC 1260
CAACTTTAAA ACCAGGCACC CGGTTAGAAG GGGGAGAGCC AGGGCTTGGC AGCGGAGGGT 1320
CCTCACCTTG CATCCAGGGA GTGGCTGAGG GCCCTTCTCG TTCTCTGTGG CTGTGCTGAG 1380
CTGAGTCAGC GAGCCCTGAA GCCTCTGGGA TTTGGGGAGT GGGGCACTGC TGGAAGGTTC 1440
TGGTTCCTGC TTTGTTCTGC TGCTGCCAGG CTTCTGGAGA GGGTGGTTGT GGGGTGAGTC 1500
CTGCGCTCCG CACGTCCACA TGTTCGTATT CTACATATTG GGCTTCTGAA AAAAGTTCTG 1560
GTTCATAAGA CGGCTTCACA GCTTAGCCGT CTGCAGACCA GTCTGCAGGT TGATCAGCTT 1620
TCTGTCATGT GTGTGCTGTT CCTGTTCACA CATGCTGCGC CGATGCCCGC CTGTGCCTGT 1680
GCCAGCCCCA GCCCACACAG CTACCTGAGA TTTAGCCCTG GGCATCTCCC CTACCCTTTC 1740
CCGCTTCCCC CTCCTCTCCT CCCTTCCTCT CCAGCTGCCT CGCCATCTGC AAGATTCTGG 1800